Dhruv Jani sells 7.22 lakh Global Longlife Hospital shares

1 min read     Updated on 13 Aug 2026, 10:32 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Promoter Dhruv Sureshkumar Jani sold 7,22,000 shares of Global Longlife Hospital and Research Ltd between August 10-12, 2026. His stake fell from 6.89% to 0.01%, leaving him with 990 shares. The open market sale was disclosed under SEBI Regulation 29(2).

powered bylight_fuzz_icon
48142917

*this image is generated using AI for illustrative purposes only.

Global Longlife Hospital and Research promoter Dhruv Sureshkumar Jani has significantly reduced his stake in the company, selling 7,22,000 equity shares through the open market. The transaction, executed between August 10 and August 12, 2026, leaves Jani with a residual holding of just 990 shares, marking a near-complete exit from his previous position.

The sale was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Prior to the transaction, Jani held 7,22,990 shares, representing 6.89% of the company’s total voting capital. Following the offloading of 7,22,000 shares, his stake dropped to 0.01%.

Transaction Details

The equity share capital of Global Longlife Hospital and Research Limited remains unchanged at ₹10,50,00,000, comprising 1,05,00,000 equity shares of ₹10 each. There were no warrants, convertible securities, or voting rights acquired or sold otherwise than by shares involved in this transaction.

Metric Before Sale Sale Details After Sale
Shares held 7,22,990 7,22,000 sold 990
Stake percentage 6.89% 6.88% sold 0.01%
Voting rights (other) - - -
Encumbrances - - -

What the Numbers Show

The transaction represents a near-total divestment by the promoter. With only 990 shares remaining out of a total capital base of 1,05,00,000 shares, Jani’s economic interest in the company is now negligible. The absence of any encumbrances or pledge details in the filing suggests the shares were freely tradable at the time of sale.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-3.81%-11.52%+11.22%-9.23%-51.65%-91.43%

How might this near-total exit by the promoter impact investor confidence and the stock's liquidity in the near term?

Are there indications of a potential change in management control or strategic direction following the promoter's divestment?

Could this sale signal broader concerns about the company's future growth prospects or financial health among insiders?

Global Longlife Hospital & Research
View Company Insights
View All News
like16
dislike

Dhruv Jani sells 10L Global Longlife shares, stake drops to 6.89%

1 min read     Updated on 10 Aug 2026, 11:59 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Dhruv Sureshkumar Jani, a promoter of Global Longlife Hospital and Research Limited, sold 10,00,000 equity shares on the BSE between August 06 and August 07, 2026. His stake decreased from 16.41% to 6.89%. The transaction was disclosed under SEBI Regulation 29(2) on August 08, 2026.

powered bylight_fuzz_icon
47888981

*this image is generated using AI for illustrative purposes only.

Promoter Dhruv Sureshkumar Jani has significantly reduced his stake in Global Longlife Hospital and Research Limited , selling 10,00,000 equity shares through open market transactions. The sale, which took place between August 06, 2026, and August 07, 2026, brings his total holding down from 16.41% to 6.89% of the company’s voting capital. This disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, notifying the Bombay Stock Exchange of the change in shareholding pattern.

The transaction represents a substantial reduction in promoter ownership, with the sale accounting for 9.52% of the total diluted share and voting capital. Prior to the sale, Jani held 17,22,990 shares carrying voting rights. Following the disposal, his remaining holding stands at 7,22,990 shares. The company’s total equity share capital remains unchanged at ₹10,50,00,000, comprising 1,05,00,000 equity shares of ₹10 each.

Transaction Details

The following table outlines the change in shareholding before and after the sale:

Metric Before Sale Shares Sold After Sale
Shares with voting rights 17,22,990 10,00,000 7,22,990
Stake percentage 16.41% 9.52% 6.89%

Jani, who is part of the promoter group, executed the sales via the open market mechanism. No voting rights were acquired or sold otherwise than by shares, and there were no warrants, convertible securities, or other instruments entitling the seller to receive shares carrying voting rights involved in this transaction. Similarly, no shares were encumbered by pledge, lien, or non-disposal undertaking at the time of filing.

Regulatory Compliance

The disclosure was submitted to BSE Limited on August 08, 2026, adhering to the mandatory reporting requirements for substantial shareholders. The filing confirms that the seller belongs to the promoter/promoter group and lists the specific dates of acquisition and sale as August 06, 2026, to August 07, 2026. The company’s total diluted share/voting capital after the sale is not applicable, as indicated in the regulatory format. This reduction in promoter stake may be monitored by investors for potential implications on corporate governance and control dynamics within the organization.

Historical Stock Returns for Global Longlife Hospital & Research

1 Day5 Days1 Month6 Months1 Year5 Years
-3.81%-11.52%+11.22%-9.23%-51.65%-91.43%

What strategic reasons might drive promoter Dhruv Sureshkumar Jani to reduce his stake from 16.41% to 6.89% in such a short timeframe?

How could this significant drop in promoter holding impact investor confidence and the stock price of Global Longlife Hospital and Research Limited?

Does the reduction in stake below 10% trigger any changes in corporate governance requirements or control dynamics for the company?

Global Longlife Hospital & Research
View Company Insights
View All News
like15
dislike

More News on Global Longlife Hospital & Research

1 Year Returns:-51.65%